Patent Application
20190038698
The present invention relates to a method for treating pleural effusion and, more particularly, to a method for treating malignant pleural effusion, comprising administering an effective amount of an chinese herbal medicine to achieve an object of treating or ameliorate pleural effusion.
As the potential of chinese herbal medicine for treating cancer, chinese herbal medicine has drawn public's attention in recent years. The principle of chinese herbal medicine application is based on the practice of traditional Chinese medicine theory.
Normally, there is 3-15 mL fluid retained in the human chest, and it has a lubricant function when breathing; however, the amount of the fluid in the chest is not fixed, but in a dynamic balance. Breaking the balance will result in forming the fluid too fast or absorbing the fluid too slow, and thus producing pleural effusion.
Pleural effusion can be divided into two categories, transudative and exudative pleural effusion, according to the causes. Transudative pleural effusion is commonly caused by systemic disease or certain organ disease, such as heart failure, kidney failure or cirrhosis. Usually pleural effusion happens on the both sides of the chest simultaneously. Exudative pleural effusion is usually caused by lung disease, such as pneumonia, pulmonary tuberculosis and the like, or by cancer, such as lung cancer, breast cancer and the like; and pleural effusion happens on the one side of the chest mostly.
Common symptoms of pleural effusion are cough, dyspnea, chest pain, easy to pant, and weakened respiration, severe cases will be accompanied with trachea to the contralateral displacement, or need of an oxygen generator to assist in breath.
Patients with non-malignant pleural effusion can significantly ameliorate or cure pleural effusion by discharging the fluid and treating the primary disease simultaneously; however, patients with malignant pleural effusion can only ameliorate or reduce the occurrence of pleural effusion since it is difficult to cure tumors. Drainage is a common way to discharge the fluid in the chest, and it can achieve the goal of discharging the fluid quickly. However, drainage alone cannot cure pleural effusion completely, after all, it is just a very effective adjuvant therapy, and the patient may continually produce the fluid in the chest; also, administering drainage in a short period of time may cause irreversible damages to the patient. Therefore, for patients with malignant pleural effusion, it is desired to treat pleural effusion with a safer or long-term treatment.
One of the objects of the present invention is to provide a method for treating malignant pleural effusion. The method for treating malignant pleural effusion comprises administering a first chinese herbal medicine, which can ameliorate or treat pleural effusion, to a subject in need; also, it can be a safer or long-term use for administering to patients with a tumor or elderly patients since it is not necessary to conduct a drainage surgery and is a non-invasive treatment; in addition, the method in the present invention provides a new treatment for the patients who are not suitable for receiving a surgery.
The present invention may further comprise administering a second chinese herbal medicine to a subject in need. The second chinese herbal medicine comprises the powder of Zhibai Dihuang Decoction, Yeh Gan Ma Hwang Tang, Ginseng, and Velvet Antler; wherein Zhibai Dihuang Decoction is traditionally used to treat yin-vacuity fire efflux, dry mouth, and sore throat, nowadays, it can also be used to treat chronic pharyngitis, acute urinary tract infection and the like; Yeh Gan Ma Hwang Tang can be used to diffuse the lung and transform phlegm, relieve asthma, relieve cough and the like, and it can be clinically applied to asthmatic bronchitis, chronic bronchitis and the like. Preferably, the second mixture is the powders comprising Radix Kansui, Euphorbia pekinensis, Flos Genkwa.
The method for treating malignant pleural effusion of the present invention comprises administering a first chinese herbal medicine to a subject in need;
wherein the first chinese herbal medicine is an extract of a first mixture comprising Poria, Grifola (Chuling), Rhizoma Atractylodis (Atractylodes lancea), Rhizoma Alismatis (Alisma plantago-aquatica), Semen Lepidii (Seed of Pepperweed), Rhizoma Atractylodis Macrocephalae (Atractylodes macrocephala), Herba Ephedrae (Ephedra), Fructus Jujubae (Chinese red date), Fructus Crataegi (Chinese Hawthorn), dried Longan, Radix Stephaniae Tetrandrae (Stephania tetrandra), and Rhizoma Gastrodiae (Gastrodia elata); Ginseng powder; and a second mixture comprising Radix Kansui (Euphorbia kansui), Euphorbia pekinensis, and Flos Genkwa (Daphne genkwa).
Preferably, the first mixture comprises 6-10 parts by weight of Poria, 6-10 parts by weight of Grifola, 6-10 parts by weight of Rhizoma Atractylodis, 13-17 parts by weight of Rhizoma Alismatis, 13-17 parts by weight of Semen Lepidii, 6-10 parts by weight of Rhizoma Atractylodis Macrocephalae, 1-5 parts by weight of Herba Ephedrae, 5-10 parts by weight of Fructus Jujubae, 2-6 parts by weight of Fructus Crataegi, 6-10 parts by weight of dried Longan, 2-6 parts by weight of Radix Stephaniae Tetrandrae, and 6-10 parts by weight of Rhizoma Gastrodiae; more preferably, the first mixture comprises 7-9 parts by weight of Poria, 7-9 parts by weight of Grifola, 7-9 parts by weight of Rhizoma Atractylodis, 14-16 parts by weight of Rhizoma Alismatis, 14-16 parts by weight of Semen Lepidii, 7-9 parts by weight of Rhizoma Atractylodis Macrocephalae, 2-4 parts by weight of Herba Ephedrae, 6-9 parts by weight of Fructus Jujubae, 3-5 parts by weight of Fructus Crataegi, 7-9 parts by weight of dried Longan, 3-5 parts by weight of Radix Stephaniae Tetrandrae, and 7-9 parts by weight of Rhizoma Gastrodiae. Preferably, the part by weight of the first mixture is 3.75 gram per part.
The amount of the Ginseng powder in the first chinese herbal medicine used in the present invention is not particularly limited, preferably 1-5 parts by weight, more preferably 2-4 parts by weight. Preferably, the part by weight of the Ginseng powder is 3.75 grams per part.
The weight ratio of the second mixture of the first chinese herbal medicine used in the present invention is not particularly limited, preferably 0.5-1.5:0.5-1.5:0.5-1.5 (Radix Kansui:Euphorbia pekinensis:Flos Genkwa), more preferably 0.8-1.2:0.8-1.2:0.8-1.2 (Radix Kansui:Euphorbia pekinensis:Flos Genkwa).
The preparation of the first chinese herbal medicine comprises: providing the first mixture; mixing the first mixture and water to form a third mixture; decocting the third mixture to obtain a crude extract; filtering the crude extract to remove a residue and obtain a liquid extract; and adding the Ginseng powder and the second mixture to the liquid extract in order to obtain the first chinese herbal medicine.
The amount of water used to form the third mixture in the present invention preferably is 425-535 parts by weight, more preferably 450-500 parts by weight. Preferably, the part by weight of the water is 3.75 grams per part.
The method for treating malignant pleural effusion of the present invention may further comprise administering a second chinese herbal medicine to a subject in need; wherein the second chinese herbal medicine is the powder of a fourth mixture comprising Zhibai Dihuang Decoction, Yeh Gan Ma Hwang Tang, Ginseng, and Velvet antler.
The fourth mixture used in the present invention preferably comprises 0.5-4 parts by weight of Zhibai Dihuang Decoction, 0.1-2 parts by weight of Yeh Gan Ma Hwang Tang, 0.1-2 parts by weight of Ginseng, and 0.05-1.5 parts by weight of Velvet Antler; more preferably 1-3 parts by weight of Zhibai Dihuang Decoction, 0.5-1.5 parts by weight of Yeh Gan Ma Hwang Tang, 0.5-1.5 parts by weight of Ginseng, and 0.1-1 parts by weight of Velvet Antler. Preferably, the part by weight of the fourth mixture is 3.75 grams per part.
The method of decoction used in the present invention is not particularly limited, and may be carried out by any method known in the art. The method of “drying” used herein is not particularly limited and may be carried out using any method known in the art, such as baking dry.
Other objects, advantages, and novel features of the invention will become more apparent from the following detailed description.
Ordinal numbers such as “first”, “second”, “fourth” and the like used in the specification and claim for modifying elements of the claim do not mean and represent the claimed elements have any antecedent ordinal number, nor do they represent the order (or order of production) between a claimed element and another claimed element. The ordinal numbers are only used to clearly distinguish certain claimed elements having the same name.
Unless specified otherwise, all technical and scientific terms set forth in the specification and claims of the present invention are defined as follows. The singular term “a”, “an”, or “the”, unless specified otherwise, refers to more than one object. The term “or” or “and” used herein, unless specified otherwise, refers to “and/or”. In addition, the term “include” or “comprise” used herein are open ended conjunctions. The preceding paragraphs are merely systematic references and should not be construed as limiting the subject matter of the invention. Unless specified otherwise, the materials used herein are commercially available, and the ways to get materials listed below are merely exemplary.
Eight parts by weight of Poria, 8 parts by weight of Grifola, 8 parts by weight of Rhizoma Atractylodis, 15 parts by weight of Rhizoma Alismatis, 15 parts by weight of Semen Lepidii, 8 parts by weight of Rhizoma Atractylodis Macrocephalae, 3 parts by weight of Herba Ephedrae, 8 parts by weight of Fructus Jujubae, 4 parts by weight of Fructus Crataegi, 8 parts by weight of dried Longan, 4 parts by weight of Radix Stephaniae Tetrandrae, and 8 parts by weight of Rhizoma Gastrodiae were provided with 480 parts by weight of water to form about 120 parts by weight of a crude extract; then filter the crude extract to remove a residue and obtain an extract of a first mixture.
Radix Kansui, Euphorbia pekinensis and Flos Genkwa were provided, dried, and co-grinded in a weight ratio of about 1:1:1 to produce about 100 grams powder, thereafter, a second mixture was obtained.
The extract of the first mixture was provided, and then added with Ginseng powder and the second mixture to obtain the first chinese herbal medicine.
Two parts by weight of Zhibai Dihuang Decoction, 1 parts by weight of Yeh Gan Ma Hwang Tang, 1 parts by weight of Ginseng, and 0.5 parts by weight of Velvet Antler were provided, and then mixed to obtain a fourth mixture.
The patient's symptoms in the Embodiment 1 were panting for light intensity activities and dramatic decrease in weight from 44 kg to 38 kg; after examination, it was found that pleural effusion shown in the right lung, and it might be malignant tumor according to computed tomography (CT) and magnetic resonance imaging (MRT) report; after lung aspiration, the patient started to pant within a week.
The treatment for the patient in the present embodiment comprises: on the first day, 1.6 g of the second mixture and 2.8 parts by weight of Ginseng powder were added to the extract of the first mixture and then divided into aliquots for ter in die administration; from day 2, the extract of the first mixture was administered together with 3 parts by weight of Ginseng powder. After two weeks, there was no pleural effusion found according to the X-ray film.
The patient in the Embodiment 2 was about 90 years old, and the patient's symptoms were cough, panting for light intensity activities and weak knees (the patient suddenly fell down during a slow-walking); the patient was diagnosed to have a pleural effusion and malignant lung tumor, and relied on oxygen generator to breathe. After lung aspiration, symptoms recurred within a week.
The treatment for the patient in the Embodiment 2 comprises: on the first day, 1.3 g of the second mixture and 3 parts by weight of Ginseng powder were added to an extract of the first mixture, and then divided into aliquots for ter in die administration. From day 2, 3 parts by weight of Ginseng powder was added to the extract of the first mixture, and then divided into aliquots for ter in die administration. After two weeks, there was no pleural effusion shown according to the X-ray film. After consecutive intake of the extract of the first mixture for about 40 days, the patient's symptom of pant was ameliorated significantly; however, the patient still coughed for dozens times and had sleeping difficulties every day, therefore, all of the aforementioned administration was stopped, and 10 g of the fourth mixture was administered to the patient once per day; and the patient barely coughed and slept well after three days.
The patient in the Embodiment 3 was 92 years old, and the patient's symptoms were cough, sudden weight loss, and panting for light intensity activities (even lying). The patient was diagnosed to have a pleural effusion in the right lung and malignant lung tumor, and relied on oxygen generator to breathe. After 200 mL fluid was aspired from the lung, the symptoms recurred within a week.
The treatment for the patient in the Embodiment 3 comprises: on the first day, 1.5 g of the second mixture and 3 parts by weight of Ginseng powder were added to an extract of the first mixture, and divided into aliquots for ter in die administration. From day 2, 3.5 parts by weight of Ginseng powder was added to the extract of the first mixture, and then divided into aliquots for ter in die administration. After two weeks, there was no pleural effusion shown according to the X-ray film. After consecutive intake of the first mixture for about 40 days, the patient's symptom of pant was ameliorated significantly, and the patient was able to do light intensity activities; however, the patient still coughed up sputum for dozens times every day, therefore, from day 41, all of the aforementioned administration was stopped, and 10 g of the powder of the fourth mixture was administered to the patient twice per day; on day 43, about 12-15 g of the powder of the fourth mixture was administered to the patient; thereafter, it was found that the patient barely coughed and panted, and did not need to rely on the oxygen generator to breathe.
Although the present invention has been explained in relation to its preferred embodiment, it is to be understood that many other possible modifications and variations can be made without departing from the spirit and scope of the invention as hereinafter claimed.
